Latest Breaking News On - Aurelius value - Page 2 : comparemela.com

VANDA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Vanda Pharmaceuticals Inc

VANDA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Vanda Pharmaceuticals Inc
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesNew orleansLewis kahnCharlesc foti jrVanda pharmaceuticals incKahn swick fotiFormer attorney generalKahn swickVanda pharmaceuticalsAurelius valueClass periodPartner lewis kahnLouisiana attorney general charlesManaging partnerபுதியது யார்க்

Case Alleging Vanda Pharmaceuticals, Execs Misled Public, Investors Partially Survives Dismissal

Health your username March 12, 2021 On Wednesday Judge Frederic Block of the Eastern District of New York partially denied a motion by Vanda Pharmaceuticals Inc. and four company executives to dismiss a class action that alleged that the defendants knowingly made statements that violated the Securities Exchange Act of 1934 in the marketing of Vanda drugs. Lead plaintiff Kenneth Gordon argued that biopharmaceutical company Vanda and officials Mihael H. Polymeropoulos, James P. Kelly, Gian Piero Reverberi, and Thomas E. Gibbs made materially misleading and false statements and omissions in the marketing of Vanda drugs Fanapt and Hetlioz, approved by the Food and Drug Administration (FDA) to treat adult schizophrenia and a circadian rhythm disorder predominantly affecting blind individuals, respectively.

Kenneth gordonMihaelh polymeropoulosThomase gibbsJamesp kellyGian piero reverberiVanda pharmaceuticals incWharton garrisonRosen law firmSecurities exchangeDrug administrationWednesday judge frederic blockEastern districtNew yorkVanda pharmaceuticalsSecurities exchange actAurelius value